Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!
📻 Siste episoder av Artificial Intelligence in Drug Discovery
Her er de nyeste episodene tilgjengelige via RSS-feeden:
Laster episoder...
📱 Slik abonnerer du på Artificial Intelligence in Drug Discovery
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus (00:32:08)
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. ...
Lucas Siow of ProteinQure on AI for Protein-Based Drugs (00:33:56)
On this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based dru...
Regina Barzilay, AI Small Molecule Discovery and Synthesis (00:28:56)
On this episode, I speak with Regina Barzilay of MIT's Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly...
Tim Guilliams and David Brown, Healx, AI for Rare Diseases (00:37:34)
On this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% fa...
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology (00:24:03)
On this episode, I speak with John Cassidy, CEO of Cambridge Cancer Genomics ( www.ccg.ai ). CCG aims to transform oncology by combining liquid biopsy with genomics and artificial intelligence to pred...
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research (00:25:31)
On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the dise...
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More (00:23:35)
On this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drug...
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology (00:31:37)
On this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can in...
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics (00:28:33)
On this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before lea...
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype (00:20:21)
On this episode, I speak with Mostapha Benhenda of Startcrowd ( http://www.startcrowd.club ). In January, Mostapha wrote a controversial article critiquing several research labs ( https://bit.ly/2qINv...
Mauro Cozzi, Researchably, AI for Better Biomedical Search (00:29:58)
On this episode, I speak with Mauro Cozzi, co-founder of Researchably ( www.researchably.com ). Researchably is a biomedical search engine that uses artificial intelligence to save researchers time—Ma...
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping" (00:30:36)
For the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA ( https://www.fdna.com/ ). FDNA enables precision medicine by using artificial intellige...
Side 1 av 1
Artificial Intelligence in Drug Discovery - Gratis RSS Feed for Norsk Podcast | OpenPodMe | OpenPodMe - Åpen RSS for Norske Podcaster
